TRIPS Waiver / Paid-only [EXCLUSIVE] Lobbying Disclosures in the US: How Big Pharma Fought the TRIPS Waiver & is Pushing for Strong Intellectual Property Protection in the Pandemic Agreement By Priti Patnaik / 28 Oct 2024
TRIPS Waiver / Paid-only Review of the TRIPS Agreement at the WTO: Reforming TRIPS for Global Equity Newsletter Edition #231 [The Files In-Depth] By Priti Patnaik / 9 Oct 2024
COVID-19 / Paid-only Reforms to the International Health Regulations Must Advance Human Rights [GUEST ESSAY]; TRIPS Extension Decision for COVID-19 Tests & Treatments Junked at WTO Ministerial Newsletter Edition #70 [Treaty Talks] By Priti Patnaik / 8 Mar 2024
COVID-19 A Wait In Vain? The USITC Report on the WTO TRIPS Extension Decision For COVID-19 Tests & Treatments Newsletter Edition #203 [The Files In-Depth] By Priti Patnaik / 29 Nov 2023
COVID-19 The WTO’s Belated Efforts to Understand if Intellectual Property Hampers Access to COVID-19 Tests & Treatments [Update: Extension of TRIPS Decision] Newsletter Edition #199 [The Files In-Depth] By Priti Patnaik / 4 Oct 2023
![[EXCLUSIVE] Lobbying Disclosures in the US: How Big Pharma Fought the TRIPS Waiver & is Pushing for Strong Intellectual Property Protection in the Pandemic Agreement](/content/images/size/w960/format/webp/substack-post-media-s3-amazonaws-com/public/images/591fd241-c258-4140-ae5f-8cf6837e92b8_5472x3648.jpg)
![Reforms to the International Health Regulations Must Advance Human Rights [GUEST ESSAY]; TRIPS Extension Decision for COVID-19 Tests & Treatments Junked at WTO Ministerial](/content/images/size/w960/format/webp/substack-post-media-s3-amazonaws-com/public/images/d496a6b0-3892-4404-9563-016713820f76_5184x3888.jpg)
![The WTO’s Belated Efforts to Understand if Intellectual Property Hampers Access to COVID-19 Tests & Treatments [Update: Extension of TRIPS Decision]](/content/images/size/w960/format/webp/substack-post-media-s3-amazonaws-com/public/images/2498d9e6-a385-434f-997a-8cec8c942c50_3024x4032.jpg)